In 2018, Eli was recognized as a “Leading Lawyer” in Corporate and M&A in Vietnam by Asia Law based on one of the largest surveys of legal professionals across the Asia-Pacific. Eli was also honored as Vietnam’s “Top Pharmaceutical Adviser” by both Advisory Excellence and LinkedIn. His combined expertise in M&A and Pharmaceutical / Health law makes him an excellent choice for M&A deals, compliance advice, and FCPA investigations in Vietnam’s complex Healthcare & Pharmaceutical sectors.
Eli is a qualified attorney and a Registered Foreign Lawyer in Vietnam, and for nearly 17 years, Eli has been a trusted legal adviser for multinational companies and private equity funds operating and investing in Vietnam, with particular expertise in health and pharmaceuticals, FCPA issues. Eli is the founder and leader of YKVN’s Healthcare and pharmaceutical Practice Group, and his clients base includes Pfizer, AstraZeneca, Ferring, Daiichi Sankyo and several other pharma group. Indeed, the practice group represents approximately 70% of the domestic pharmaceutical industry by revenue.
Eli graduated from Duke Law School, served on the Executive Board of the Duke Law Journal, and also served as a Judicial Law Clerk on both the U.S. District Court in Charlotte, North Carolina and the U.S. Court of Appeals for the Fourth Circuit in Richmond, Virginia.
Fluent in Vietnamese, Eli is highly regarded by clients and peers as a practical, commercial lawyer serving clients with his deal execution abilities, well-conceived strategies. But also, for his discretion as a problem-solver, as a crisis mitigation expert, and for his ability to assist clients develop and maintain successful long-term commercial partnerships in Vietnam.
Specialties: Health, Pharmaceuticals, Corporate, M&A, Project Finance, FCPA, and International Family Law